Clay Preparations Destroy Antibiotic-Resistant Bacteria
|
By HospiMedica International staff writers Posted on 30 Jul 2014 |

Image: French green clays used for healing Buruli ulcers (Photo courtesy of Thierry Brunet de Courssou/ASU).
Natural clay deposits with antibacterial properties could provide a possible solution for killing pathogens resistant to multiple antibiotics.
Researchers at Arizona State University (ASU; Phoenix, USA) set out to identify naturally-occurring clays that are effective at killing antibiotic-resistant bacteria. The scientists examined mineralized clay deposits near Crater Lake (OR, USA), in an area mined by Oregon Mineral Technologies (OMT; Jackson, USA). The clay, formed by volcanic activity millions of years ago, had turned into bluish clay known as K Rectorite. The clay contains over 40 minerals, including silicon, aluminum, iron, potassium, magnesium, calcium, sodium, manganese, sulfur, and phosphate.
The researchers hypothesized that the clays buffer pH (acidity)and Eh (oxidation) to dissolve unstable mineral phases containing transition metals (primarily Fe2+), while smectite interlayers serve as reservoirs for time release of bactericidal components. They then incubated the pathogens Escherichia coli and Staphylococcus epidermidis with clays from different zones. They found that rapid uptake of Fe2+ impaired bacterial metabolism by flooding the cell and overwhelming iron storage proteins. As the intracellular Fe2+ oxidized, it produced reactive oxygen species that damage biomolecules and precipitates Fe-oxides. The study was published in the August 2014 issue of Environmental Geochemistry and Health.
“As antibiotic-resistant bacterial strains emerge and pose increasing health risks, new antibacterial agents are urgently needed. Antibacterial clays may shift the wound environment to a pH range that favors healing, while killing invading bacteria,” said senior author biogeochemist Lynda Williams, PhD. “The ability of antibacterial clays to buffer pH also appears key to their healing potential and viability as alternatives to conventional antibiotics.”
Green clays, historically used in France in mineral baths, have been used to treat Mycobacterium ulcerans, the pathogen that causes Buruli ulcers. The infections, which lead to the destruction of skin and large, open ulcers on arms or legs, can be treated with daily applications of green clay poultices to heal the infections. Unfortunately, the original French green clays have been depleted, and later testing of newer samples did not show the same results.
Related Links:
Arizona State University
Oregon Mineral Technologies
Researchers at Arizona State University (ASU; Phoenix, USA) set out to identify naturally-occurring clays that are effective at killing antibiotic-resistant bacteria. The scientists examined mineralized clay deposits near Crater Lake (OR, USA), in an area mined by Oregon Mineral Technologies (OMT; Jackson, USA). The clay, formed by volcanic activity millions of years ago, had turned into bluish clay known as K Rectorite. The clay contains over 40 minerals, including silicon, aluminum, iron, potassium, magnesium, calcium, sodium, manganese, sulfur, and phosphate.
The researchers hypothesized that the clays buffer pH (acidity)and Eh (oxidation) to dissolve unstable mineral phases containing transition metals (primarily Fe2+), while smectite interlayers serve as reservoirs for time release of bactericidal components. They then incubated the pathogens Escherichia coli and Staphylococcus epidermidis with clays from different zones. They found that rapid uptake of Fe2+ impaired bacterial metabolism by flooding the cell and overwhelming iron storage proteins. As the intracellular Fe2+ oxidized, it produced reactive oxygen species that damage biomolecules and precipitates Fe-oxides. The study was published in the August 2014 issue of Environmental Geochemistry and Health.
“As antibiotic-resistant bacterial strains emerge and pose increasing health risks, new antibacterial agents are urgently needed. Antibacterial clays may shift the wound environment to a pH range that favors healing, while killing invading bacteria,” said senior author biogeochemist Lynda Williams, PhD. “The ability of antibacterial clays to buffer pH also appears key to their healing potential and viability as alternatives to conventional antibiotics.”
Green clays, historically used in France in mineral baths, have been used to treat Mycobacterium ulcerans, the pathogen that causes Buruli ulcers. The infections, which lead to the destruction of skin and large, open ulcers on arms or legs, can be treated with daily applications of green clay poultices to heal the infections. Unfortunately, the original French green clays have been depleted, and later testing of newer samples did not show the same results.
Related Links:
Arizona State University
Oregon Mineral Technologies
Latest Critical Care News
- Wearable Patch Provides Up-To-The-Minute Readouts of Medication Levels in Body
- New Spray-Mist Device Delivers Antibiotics Directly into Infected Tissue
- Living Implant Could End Daily Insulin Injections
- Intelligent Camera System Continuously Monitors Premature Babies in NICU
- Intranasal Spray to Prevent Illnesses from Respiratory Viruses
- Gut Bacteria from Amphibians and Reptiles Show Complete Tumor Elimination
- High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy
- AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
- Glowing Bacterial Sensors Could Improve Detection of Gut Illness
- Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment

- New Nanomaterial Kills Cancer Cells While Sparring Healthy Tissues
- AI Model Accurately Predicts Neurological Recovery After Cardiac Arrest
- Battery-Free Nano-Sensors Pave Way for Next-Generation Wearables
- Imaging Technology Detects Early Signs of Cardiovascular Risk Through Skin
- New Therapeutic Approach Marks Breakthrough in Pediatric Heart Disease
- AI Model Accurately Identifies Prediabetics Using Only ECG Data
Channels
Artificial Intelligence
view channelSurgical Techniques
view channel
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read more
New Imaging Combo Offers Hope for High-Risk Heart Patients
Patients with type 2 diabetes often develop complex, severe coronary artery disease involving multiple narrowed or blocked arteries, making complete revascularization difficult. Without detailed functional... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







